Company / Current Assets
Cytosorbents Corp Current Assets History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$28.3M
FY2018
5-year range
$7.6M / $28.3M
FY2014-FY2018
Trend
+36.3%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $8M to $28M over the past 2 years.
Based on SEC 10-K filings.
$28M in FY2018 with a 5-year CAGR of +52.0%.
Improved from $8M to $28M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +42.1%
- 5-Year CAGR
- +52.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +52.0%, indicating consistent growth.
- In FY2018, current assets increased 36.3% year-over-year.
- Lowest current assets in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $28.3M | +36.3% |
| FY2017 | $20.7M | +164.9% |
| FY2016 | $7.8M | -20.6% |
| FY2015 | $9.9M | +29.6% |
| FY2014 | $7.6M | +118.2% |
| FY2013 | $3.5M | +18.6% |
| FY2012 | $2.9M | +73.2% |
| FY2011 | $1.7M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026